Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Most doctors know the thrombosis risk with Cyproterone/Ethinylestradiol, but some lack details on less common risks and patient instructions; educational materials are underused but useful.

The injectable hydrogel effectively speeds up chronic wound healing.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

Birth control pills increase the risk of blood clots, especially within the first year and with certain types.

New oral anticoagulants are safer and easier to use with new reversal agents for bleeding emergencies.

Platelet-rich plasma may help heal injuries.

Valproic acid can cause low platelet counts, especially at high doses or in elderly patients.

EBGS reduces platelet adhesion, potentially helping prevent blood clots.

Different oral anticoagulants cause various non-bleeding side effects, so careful monitoring is needed.

CTP-543 is generally safe for treating alopecia areata.

PEGylated thymosin β4 shows promise for treating heart attacks effectively.

Spanlastic formulations improve rivaroxaban's oral anticoagulation efficiency.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

Clindamycin-loaded nanoparticles effectively treat MRSA-infected wounds and promote healing.

CDK4/6 inhibitors affect safety and quality of life differently, requiring careful use.

Plumbago zeylanica L. leaves may help dissolve blood clots and have antioxidant benefits.

The use of Diane-35 and its generics significantly decreased in the Netherlands.

Eculizumab helps reduce blood transfusions and stabilize hemoglobin but increases infection risk and is expensive.

A compound from brown algae boosts the production of a certain inflammatory substance in skin cells.

Treprostinil, a drug, can delay wound healing in healthy cells but doesn't affect diabetic foot ulcer cells, suggesting further research could help understand its role in treating these ulcers.

CPGel hydrogel heals diabetic wounds effectively in 21 days.

Monitoring for adverse effects in clinical treatments is crucial.